Safety and effectiveness of collagenase clostridium histolyticum in the treatment of Peyronie's disease using a new modified shortened protocol

被引:73
作者
Raheem, Amr Abdel [1 ,2 ,3 ,4 ]
Capece, Marco [1 ,2 ,3 ]
Kalejaiye, Odunayo [1 ,2 ,3 ]
Abdel-Raheem, Tarek [1 ,2 ,3 ]
Falcone, Marco [1 ,2 ,3 ]
Johnson, Mark [1 ,2 ,3 ]
Ralph, Oliver G. [1 ,2 ,3 ]
Garaffa, Giulio [1 ,2 ,3 ]
Christopher, Andrew N. [1 ,2 ,3 ]
Ralph, David J. [1 ,2 ,3 ]
机构
[1] Univ Coll London Hosp, Androl Dept, London, England
[2] Inst Urol London, London, England
[3] St Peters Androl Ctr, London, England
[4] Cairo Univ Hosp, Androl Dept, Cairo, Egypt
关键词
Peyronie's disease; collagenase clostridium histolyticum; Xiapex((R)); Xiaflex((R)); intralesional injections; NATURAL-HISTORY; THERAPY; MEN;
D O I
10.1111/bju.13932
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
ObjectivesTo evaluate the efficacy and safety of collagenase clostridium histolyticum (CCH; Xiapex((R)), Xiaflex((R))) in the treatment of Peyronie's disease (PD) using a new modified treatment protocol that aims at reducing the number of injections needed and reducing patient visits, thus reducing the duration and cost of treatment. Patients and MethodsA prospective study of 53 patients with PD who had treatment with CCH at a single centre using a new modified protocol. The angle of curvature assessment after an intracavernosal injection of prostaglandin E1, the International Index of Erectile Function (IIEF) and Peyronie's Disease Questionnaire (PDQ) were completed at baseline and at week 12 (4 weeks after the last injection). The Global Assessment of Peyronie's disease (GAPD) questionnaire was completed at week 12. Under a penile block of 10 mL plain lignocaine 1%, a total of three intralesional injections of CCH (0.9 mg) were given at 4-weekly intervals using a new modified injection technique. In between injections patients used a combination of home modelling, stretching and a vacuum device on a daily basis to mechanically stretch the plaque. Investigator modelling was not performed. ResultsThe mean (range) penile curvature at baseline was 54 (30-90)degrees. Of the 53 patients in the study, 51 patients (96.2%) had an improvement in the angel of curvature by a mean (range) of 17.36 (0-40)degrees or 31.4 (0-57)% from baseline after three CCH injections. The final mean (range) curvature was 36.9 (12-75)degrees (P < 0.001). There was an improvement in each of the IIEF questionnaire domains, all three PDQ domains and the GAPD. CCH was well tolerated by all patients with only mild and transient local adverse events. ConclusionThe new shortened protocol using CCH treatment is safe, effective, and cost efficient. The results of using only three CCH injections according to this modified protocol are comparable to those of the clinical trials that used eight CCH injections.
引用
收藏
页码:717 / 723
页数:7
相关论文
共 22 条
[1]   Peyronie's disease (CME) [J].
Bella, Anthony J. ;
Perelman, Michael A. ;
Brant, William O. ;
Lue, Tom F. .
JOURNAL OF SEXUAL MEDICINE, 2007, 4 (06) :1527-1537
[2]   Risk factors for Peyronie's disease: a case-control study [J].
Bjekic, MD ;
Vlajinac, HD ;
Sipetic, SB ;
Marinkovic, JM .
BJU INTERNATIONAL, 2006, 97 (03) :570-574
[3]   Penile Duplex Ultrasonography in Men with Peyronie's Disease: Is it Veno-Occlusive Dysfunction or Poor Cavernosal Arterial Inflow that Contributes to Erectile Dysfunction? [J].
Chung, Eric ;
Young, Ling De ;
Brock, Gerald B. .
JOURNAL OF SEXUAL MEDICINE, 2011, 8 (12) :3446-3451
[4]   Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies [J].
Gelbard, Martin ;
Goldstein, Irwin ;
Hellstrom, Wayne J. G. ;
McMahon, Chris G. ;
Smith, Ted ;
Tursi, James ;
Jones, Nigel ;
Kaufman, Gregory J. ;
Carson, Culley C. .
JOURNAL OF UROLOGY, 2013, 190 (01) :199-207
[5]   THE NATURAL-HISTORY OF PEYRONIES DISEASE [J].
GELBARD, MK ;
DOREY, F ;
JAMES, K .
JOURNAL OF UROLOGY, 1990, 144 (06) :1376-1379
[6]   The Impact of Peyronie's Disease on the Patient: Gaps in Our Current Understanding [J].
Goldstein, Irwin ;
Hartzell, Rose ;
Shabsigh, Ridwan .
JOURNAL OF SEX & MARITAL THERAPY, 2016, 42 (02) :178-190
[7]   Use of Penile Extender Device in the Treatment of Penile Curvature as a Result of Peyronie's Disease. Results of a Phase II Prospective Study [J].
Gontero, Paolo ;
Di Marco, Massimiliano ;
Giubilei, Gianluca ;
Bartoletti, Riccardo ;
Pappagallo, Giovanni ;
Tizzani, Alessandro ;
Mondaini, Nicola .
JOURNAL OF SEXUAL MEDICINE, 2009, 6 (02) :558-566
[8]  
Herati Amin S, 2016, Sex Med Rev, V4, P85, DOI 10.1016/j.sxmr.2015.10.002
[9]  
Kadioglu A, 2001, BJU INT, V88, P727
[10]   A survey of primary-care physicians and urologists regarding Peyronie's disease [J].
LaRochelle, Jeffrey C. ;
Levine, Laurence A. .
JOURNAL OF SEXUAL MEDICINE, 2007, 4 (04) :1167-1173